Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
KRYS.OQ - Krystal Biotech Inc
Krystal Biotech Inc at Bank of America Global Healthcare Conference
May 13, 2026 / 06:20PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, I guess we can get going here. Thanks for joining this session with Crystal Biotech. My name is Alex Stranahan. I'm SMID Biotech Analyst at Bank of America covering Crystal. And it's my pleasure to introduce Krish Krishnan, Chief Executive Officer and Suma Krishnan, President and Head of Research and Development at Crystal. Thanks for being here, guys. Thanks for having us, Alex. Yeah, good to see you again.
Maybe at a high level, just taking a flyover of the company in its current state, you've delivered 11 consecutive quarters, maybe 12 of positive EPS. I've lost count.
Gross margins consistently in the 90%, 95% range. So you've really built a good sustainable business model and a
Trustpilot
